Toggle navigation
Home
Search
Services
Blog
Contact
About
In Vitro Antineoplastic Drug
Murphy, Martin J.
Hipple Cancer Research Corporation, Dayton, OH, United States
Search 58 grants from Martin Murphy
Search grants from Hipple Cancer Research Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Revealing the transcriptomic basis of neuronal identity through functional meta-analysis
Stabilization and regulation of a Bacillus anthracis spore lytic enzyme
Human Keratin (K14)-MBP/MBP-TCR Transgenic Animal Model
Minority Predoctoral Fellowship Program
Health Technologies'Costs and Outcomes in the Elderly
Recently added grants:
Induction of retinal development by the peripodial epithelium in Drosophila
Blood outer retina barrier regulation
Suprachoroidal nonviral gene transfer of engineered VEGF antagonists
Development of a Behavioral Intervention with Socially Assistive Robots to Enhance Magnification Device Use for Reading
BMP2/ALKs signaling system in diabetic retinopathy
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM007361-000
Application #
3608305
Study Section
Project Start
1990-09-28
Project End
Budget Start
1990-09-28
Budget End
1991-03-27
Support Year
Fiscal Year
1990
Total Cost
Indirect Cost
Institution
Name
Hipple Cancer Research Corporation
Department
Type
DUNS #
City
Dayton
State
OH
Country
United States
Zip Code
45439
Publications
Erickson-Miller, C L; May, R D; Tomaszewski, J et al.
(1997)
Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro.
Cancer Chemother Pharmacol 39:467-72
Comments
Be the first to comment on Martin Murphy's grant